Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Size & Outlook
Mexico cell & gene therapy bioanalytical testing services market, 2018-2030 (US$M)
Related Markets
Mexico is the second-biggest pharmaceutical market in Latin America after Brazil, and the 15th-largest pharmaceutical market worldwide, according to data released in November 2023 by the International Trade Administration. Furthermore, 51% of the nation's pharmaceutical market is made up of patented medications; 35% is made up of generics; and the remaining 14% is made up of over-the-counter goods. As a result, the growing pharmaceutical market is boosting the demand for advanced therapies in Mexico, which is in turn fueling the demand for cell and gene therapy bioanalytical testing services. Furthermore, Mexico has a long history of conducting life sciences and biological applications research. In Mexico, there are over 180 companies that create and apply modern biotechnology. Many of these companies are multinational conglomerates engaged in biotechnology-related activities with significant applicability in the following domains: energy production, agriculture, human healthcare, and marine resources. The industry benefits from R&D initiatives involving research institutions and the private sector, as well as from government & private sector modernization. cell & gene therapy bioanalytical testing services market highlights
- The Mexico cell & gene therapy bioanalytical testing services market generated a revenue of USD 5.6 million in 2023 and is expected to reach USD 9.3 million by 2030.
- The Mexico market is expected to grow at a CAGR of 7.4% from 2024 to 2030.
- In terms of segment, bioavailability & bioequivalence studies was the largest revenue generating test type in 2023.
- Bioavailability & Bioequivalence Studies is the most lucrative test type segment registering the fastest growth during the forecast period.
Cell & gene therapy bioanalytical testing services market data book summary
| Market revenue in 2023 | USD 5.6 million |
| Market revenue in 2030 | USD 9.3 million |
| Growth rate | 7.4% (CAGR from 2023 to 2030) |
| Largest segment | Bioavailability & bioequivalence studies |
| Fastest growing segment | Bioavailability & Bioequivalence Studies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Other test type |
| Key market players worldwide | IQVIA Holdings Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, Charles River Laboratories International Inc, Syneos Health, Intertek Group PLC |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.1% of the global cell & gene therapy bioanalytical testing services market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil cell & gene therapy bioanalytical testing services market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 20.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell & Gene Therapy Bioanalytical Testing Services Market Scope
Cell & Gene Therapy Bioanalytical Testing Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico cell & gene therapy bioanalytical testing services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell & gene therapy bioanalytical testing services market will help companies and investors design strategic landscapes.
Bioavailability & bioequivalence studies was the largest segment with a revenue share of 35.71% in 2023. Horizon Databook has segmented the Mexico cell & gene therapy bioanalytical testing services market based on bioavailability & bioequivalence studies, pharmacokinetics, pharmacodynamics, other test type covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is the second-biggest pharmaceutical market in Latin America after Brazil, and the 15th-largest pharmaceutical market worldwide, according to data released in November 2023 by the International Trade Administration.
Furthermore, 51% of the nation's pharmaceutical market is made up of patented medications; 35% is made up of generics; and the remaining 14% is made up of over-the-counter goods. As a result, the growing pharmaceutical market is boosting the demand for advanced therapies in Mexico, which is in turn fueling the demand for cell and gene therapy bioanalytical testing services.
Furthermore, Mexico has a long history of conducting life sciences and biological applications research. In Mexico, there are over 180 companies that create and apply modern biotechnology. Many of these companies are multinational conglomerates engaged in biotechnology-related activities with significant applicability in the following domains: energy production, agriculture, human healthcare, and marine resources.
Reasons to subscribe to Mexico cell & gene therapy bioanalytical testing services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico cell & gene therapy bioanalytical testing services market databook
-
Our clientele includes a mix of cell & gene therapy bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico cell & gene therapy bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Mexico cell & gene therapy bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico cell & gene therapy bioanalytical testing services market size, by test type, 2018-2030 (US$M)
Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
